Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.046 EUR | -2.14% |
|
-2.17% | -14.02% |
09/07 | EVOTEC : Deutsche Bank reiterates its Neutral rating | ZD |
26/06 | EVOTEC : Warburg Research remains its Buy rating | ZD |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.41 | 1.33 | 0.57 | 0.03 | -2.37 | |||||
Return on Total Capital | 2.96 | 1.58 | 0.71 | 0.04 | -3.14 | |||||
Return On Equity % | 1.04 | 20.5 | -13.7 | -7.27 | -18.92 | |||||
Return on Common Equity | 1.04 | 20.5 | -13.7 | -7.27 | -18.92 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 25.1 | 24.52 | 23.16 | 22.4 | 14.41 | |||||
SG&A Margin | 15.34 | 17.06 | 20.79 | 21.71 | 23.61 | |||||
EBITDA Margin % | 17.63 | 14.45 | 10.88 | 9.22 | 0.08 | |||||
EBITA Margin % | 12.6 | 8.02 | 3.69 | 0.91 | -9.15 | |||||
EBIT Margin % | 10.18 | 6.35 | 2.71 | 0.13 | -9.9 | |||||
Income From Continuing Operations Margin % | 1.25 | 34.87 | -23.38 | -10.74 | -24.6 | |||||
Net Income Margin % | 1.25 | 34.87 | -23.38 | -10.74 | -24.6 | |||||
Net Avail. For Common Margin % | 1.25 | 34.87 | -23.38 | -10.74 | -24.6 | |||||
Normalized Net Income Margin | 3.54 | 2.37 | 0.99 | -1.83 | -7.2 | |||||
Levered Free Cash Flow Margin | -3.66 | 0.79 | -20.01 | -8.93 | -10.78 | |||||
Unlevered Free Cash Flow Margin | -2.6 | 1.72 | -18.91 | -7.99 | -9.86 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.38 | 0.33 | 0.33 | 0.35 | 0.38 | |||||
Fixed Assets Turnover | 1.75 | 1.5 | 1.32 | 1.07 | 0.98 | |||||
Receivables Turnover (Average Receivables) | 5.12 | 4.87 | 4.23 | 4.8 | 5.58 | |||||
Inventory Turnover (Average Inventory) | 30.84 | 23.69 | 20.76 | 19.97 | 22 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.16 | 3.39 | 3.18 | 1.94 | 1.98 | |||||
Quick Ratio | 2.9 | 3.19 | 2.89 | 1.74 | 1.74 | |||||
Operating Cash Flow to Current Liabilities | 0.21 | 0.38 | 0.6 | 0.08 | 0.05 | |||||
Days Sales Outstanding (Average Receivables) | 71.45 | 74.96 | 86.37 | 76.07 | 65.61 | |||||
Days Outstanding Inventory (Average Inventory) | 11.87 | 15.41 | 17.58 | 18.27 | 16.64 | |||||
Average Days Payable Outstanding | 35.76 | 43.9 | 53.32 | 69.58 | 59.03 | |||||
Cash Conversion Cycle (Average Days) | 47.56 | 46.46 | 50.63 | 24.76 | 23.22 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 68.06 | 37.23 | 42.68 | 55.92 | 46.13 | |||||
Total Debt / Total Capital | 40.5 | 27.13 | 29.91 | 35.86 | 31.57 | |||||
LT Debt/Equity | 63.91 | 33.56 | 41.3 | 42.6 | 41.23 | |||||
Long-Term Debt / Total Capital | 38.03 | 24.45 | 28.95 | 27.32 | 28.22 | |||||
Total Liabilities / Total Assets | 50.59 | 38.36 | 47.41 | 50.28 | 50.19 | |||||
EBIT / Interest Expense | 6.03 | 4.24 | 1.55 | 0.09 | -6.75 | |||||
EBITDA / Interest Expense | 12.33 | 11.36 | 7.64 | 7.94 | 1.9 | |||||
(EBITDA - Capex) / Interest Expense | 0.62 | -1.49 | -6.15 | -10.24 | -8.14 | |||||
Total Debt / EBITDA | 4.71 | 4.88 | 5.05 | 6.72 | 19.81 | |||||
Net Debt / EBITDA | 0.1 | -3.28 | -2.11 | 0.24 | 1.92 | |||||
Total Debt / (EBITDA - Capex) | 93.35 | -37.2 | -6.26 | -5.21 | -4.61 | |||||
Net Debt / (EBITDA - Capex) | 1.9 | 25.04 | 2.62 | -0.18 | -0.45 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 12.2 | 23.38 | 21.59 | 3.99 | 1.99 | |||||
Gross Profit, 1 Yr. Growth % | -5.38 | 20.52 | 14.86 | 0.57 | -34.37 | |||||
EBITDA, 1 Yr. Growth % | -17.97 | 0.53 | -8.46 | -14.01 | -99.1 | |||||
EBITA, 1 Yr. Growth % | -27.21 | -21.05 | -44 | -75.71 | -1.12T | |||||
EBIT, 1 Yr. Growth % | -32.22 | -22.55 | -48.18 | -95.19 | -7.97T | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -83.21 | 3.33T | -181.51 | -52.23 | 133.67 | |||||
Net Income, 1 Yr. Growth % | -83.58 | 3.33T | -181.51 | -52.23 | 133.67 | |||||
Normalized Net Income, 1 Yr. Growth % | -59.85 | -11.3 | -49.29 | -272.55 | 300.45 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -84 | 3.14T | -176.77 | -52.29 | 134.03 | |||||
Accounts Receivable, 1 Yr. Growth % | 5.72 | 52.57 | 31.94 | -39.01 | 31.57 | |||||
Inventory, 1 Yr. Growth % | 26.38 | 89.86 | 15.63 | 3.57 | 0.75 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 41.06 | 43.67 | 34.17 | 24.05 | 2.15 | |||||
Total Assets, 1 Yr. Growth % | 23.88 | 52.85 | 0.99 | -0.21 | -15.09 | |||||
Tangible Book Value, 1 Yr. Growth % | 265.32 | 187.37 | -18.43 | -6.72 | -22.39 | |||||
Common Equity, 1 Yr. Growth % | 51.53 | 90.17 | -13.83 | -5.67 | -14.95 | |||||
Cash From Operations, 1 Yr. Growth % | 5.93 | 173.33 | 66.16 | -82.3 | -50 | |||||
Capital Expenditures, 1 Yr. Growth % | 216.3 | 20.06 | 52.47 | 17.63 | -44.93 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -156.17 | -126.24 | -3.19T | -52.99 | 23.08 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -134.95 | -180.35 | -1.43T | -55.46 | 25.83 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 15.51 | 17.66 | 22.48 | 12.44 | 2.98 | |||||
Gross Profit, 2 Yr. CAGR % | 5.95 | 6.79 | 17.66 | 7.48 | -18.76 | |||||
EBITDA, 2 Yr. CAGR % | -3.1 | -9.41 | -5.66 | -10.17 | -92.09 | |||||
EBITA, 2 Yr. CAGR % | -8.56 | -24.58 | -35.05 | -62.08 | 87.05 | |||||
EBIT, 2 Yr. CAGR % | -10.89 | -27.57 | -37.39 | -84.01 | 94.55 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -72.73 | 140.33 | 428.96 | -37.6 | 5.65 | |||||
Net Income, 2 Yr. CAGR % | -72.75 | 137.66 | 428.96 | -37.6 | 5.65 | |||||
Normalized Net Income, 2 Yr. CAGR % | -30.74 | -42.09 | -34.41 | -1.16 | 162.87 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -73.27 | 127.6 | 398.56 | -39.48 | 5.66 | |||||
Accounts Receivable, 2 Yr. CAGR % | 28.42 | 27 | 41.88 | -10.29 | -10.42 | |||||
Inventory, 2 Yr. CAGR % | 54.92 | 54.91 | 48.17 | 9.44 | 2.15 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 93.88 | 42.69 | 38.84 | 29.01 | 12.57 | |||||
Total Assets, 2 Yr. CAGR % | 37.67 | 37.58 | 24.24 | 0.39 | -7.95 | |||||
Tangible Book Value, 2 Yr. CAGR % | 118.1 | 225.38 | 53.11 | -12.77 | -14.92 | |||||
Common Equity, 2 Yr. CAGR % | 30.57 | 69.94 | 28.01 | -9.84 | -10.43 | |||||
Cash From Operations, 2 Yr. CAGR % | -46.5 | 70.16 | 113.11 | -45.4 | -70.25 | |||||
Capital Expenditures, 2 Yr. CAGR % | 88.55 | 94.87 | 35.3 | 33.92 | -19.52 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -56.45 | -61.18 | 190.69 | 278.73 | -21.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -63.58 | -46.32 | 237.18 | 142.19 | -25.14 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 23.84 | 18.08 | 18.95 | 15.98 | 8.85 | |||||
Gross Profit, 3 Yr. CAGR % | 15.41 | 10.6 | 9.41 | 11.66 | -8.82 | |||||
EBITDA, 3 Yr. CAGR % | 16.32 | -1.7 | -9.09 | -7.77 | -80.61 | |||||
EBITA, 3 Yr. CAGR % | 13.92 | -13.09 | -31.7 | -52.33 | 13.76 | |||||
EBIT, 3 Yr. CAGR % | 11.72 | -15.16 | -35.22 | -73.16 | 26.24 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -35.42 | 36.87 | 67.6 | 137.32 | -3.1 | |||||
Net Income, 3 Yr. CAGR % | -35.66 | 36.8 | 66.35 | 137.32 | -3.1 | |||||
Normalized Net Income, 3 Yr. CAGR % | 2.36 | -26.48 | -44.6 | -6.07 | 57.57 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -37 | 32.24 | 58.43 | 128.03 | -5.01 | |||||
Accounts Receivable, 3 Yr. CAGR % | 21.01 | 36.01 | 28.63 | 7.08 | 1.92 | |||||
Inventory, 3 Yr. CAGR % | 34.62 | 65.79 | 40.52 | 31.5 | 6.46 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 64.93 | 75.72 | 39.79 | 33.72 | 19.35 | |||||
Total Assets, 3 Yr. CAGR % | 29.96 | 42.53 | 24.1 | 15.49 | -5.06 | |||||
Tangible Book Value, 3 Yr. CAGR % | 144.25 | 139.78 | 105.17 | 29.79 | -16.1 | |||||
Common Equity, 3 Yr. CAGR % | 29.75 | 48.11 | 35.52 | 15.63 | -11.57 | |||||
Cash From Operations, 3 Yr. CAGR % | 60.44 | -7.86 | 68.82 | -6.6 | -46.98 | |||||
Capital Expenditures, 3 Yr. CAGR % | 79.16 | 62.21 | 79.57 | 29.13 | -0.42 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 41.98 | -63.07 | 66.97 | 57.72 | 160.38 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 21.92 | -52.31 | 56.67 | 70.96 | 94.7 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 31.44 | 30.31 | 23.29 | 15.79 | 12.29 | |||||
Gross Profit, 5 Yr. CAGR % | 29.05 | 20.95 | 16.3 | 9.34 | -2.87 | |||||
EBITDA, 5 Yr. CAGR % | 64.27 | 20.48 | 7.82 | -5.18 | -64.08 | |||||
EBITA, 5 Yr. CAGR % | 109.01 | 14.35 | -8.26 | -37.63 | -3.49 | |||||
EBIT, 5 Yr. CAGR % | 73.58 | 10.02 | -11.09 | -56.48 | 1.09 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -17.66 | 51.68 | 49.89 | -0.03 | 39.35 | |||||
Net Income, 5 Yr. CAGR % | -17.66 | 50.91 | 49.56 | -0.06 | 38.73 | |||||
Normalized Net Income, 5 Yr. CAGR % | 64.24 | -3.03 | -14.74 | -17.24 | 5.58 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -19.73 | 45.3 | 44.1 | -3.27 | 34.73 | |||||
Accounts Receivable, 5 Yr. CAGR % | 36.68 | 40.21 | 28.96 | 15.15 | 11.3 | |||||
Inventory, 5 Yr. CAGR % | 34.1 | 43.06 | 39.89 | 40.41 | 23.69 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 54.48 | 62.46 | 54.1 | 55.29 | 28.19 | |||||
Total Assets, 5 Yr. CAGR % | 38.36 | 44.56 | 27.63 | 23.89 | 10.12 | |||||
Tangible Book Value, 5 Yr. CAGR % | 26.83 | 63.27 | 102.97 | 60.01 | 44.28 | |||||
Common Equity, 5 Yr. CAGR % | 31.26 | 45.26 | 29.11 | 21.44 | 14.83 | |||||
Cash From Operations, 5 Yr. CAGR % | 23.37 | 12.66 | 79.74 | -25.26 | -15.47 | |||||
Capital Expenditures, 5 Yr. CAGR % | 54.81 | 64.6 | 60.12 | 50.24 | 30.26 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -8.24 | -24.77 | 88.01 | -6.29 | 21.61 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -14.93 | -12.81 | 81.64 | -8.65 | 16.29 |
- Stock Market
- Equities
- EVT Stock
- Financials Evotec SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition